VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 172 filers reported holding HAEMONETICS CORP in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2015$23,402,000
-33.7%
565,825
-28.0%
0.33%
-38.8%
Q1 2015$35,315,000
-46.2%
786,175
-55.2%
0.54%
-43.7%
Q4 2014$65,616,000
+21.8%
1,753,500
+13.7%
0.96%
+18.8%
Q3 2014$53,866,000
+17.0%
1,542,550
+18.2%
0.80%
+23.1%
Q2 2014$46,031,0001,304,7500.65%
Other shareholders
HAEMONETICS CORP shareholders Q4 2014
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders